Status:
COMPLETED
MR Metabolic Biomarkers for Cervical Cancer
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Uterine Cervical Neoplasms
Eligibility:
FEMALE
20-80 years
Brief Summary
The purposes of this study are: (1) to develop magnetic resonance (MR) imaging and spectroscopy as surrogate biomarkers for altered cancer metabolism in cervical cancer; (2) to understand the function...
Detailed Description
In the first part of this project, we aim to identify the differences in cancer metabolism between normal and cervical cancer. Conventional MR study plus magnetic resonance spectroscopy (MRS) and diff...
Eligibility Criteria
Inclusion
- be able to give informed consent.
- female patients between 20 and 80 years of age.
- biopsy proven newly diagnosed cervical cancer clinical stage International Federation of Gynecology and Obstetrics (FIGO) Ib and above.
- patients must be willing to undergo standard treatment such as surgery or chemo-radiation therapy.
Exclusion
- patients who are judged to be noncompliant to treatment or not accessible for follow up.
- patients with contraindications to magnetic resonance imaging (MRI) scanning, such as claustrophobia, cardiac pacemaker, metal implants in field of view, or unable to cooperate for MRI study due to mental status.
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT01874548
Start Date
July 1 2013
End Date
June 1 2016
Last Update
August 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiology, Chang Gung Memorial Hospital
Guishan, Taoyuan, Taiwan, 333